Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Diseases

  Free Subscription


Articles published in Cancer Res

Retrieve available abstracts of 31 articles:
HTML format
Text format



Single Articles


    February 2017
  1. LIN DC, Mayakonda A, Dinh HQ, Huang P, et al
    Genomic and epigenomic heterogeneity of hepatocellular carcinoma.
    Cancer Res. 2017 Feb 20. pii: canres.2822.2016.
    PubMed     Text format     Abstract available


  2. YAN C, Yang Q, Gong Z
    Tumor-associated neutrophils and macrophages promote gender disparity in hepatocellular carcinoma in zebrafish.
    Cancer Res. 2017 Feb 15. pii: canres.2200.2016.
    PubMed     Text format     Abstract available


    January 2017
  3. LUO C, Cheng Y, Liu Y, Chen L, et al
    SRSF2 regulates alternative splicing to drive hepatocellular carcinoma development.
    Cancer Res. 2017 Jan 12. pii: canres.1919.2016.
    PubMed     Text format     Abstract available


    December 2016
  4. MALAKAR P, Shilo A, Mogilavsky A, Stein I, et al
    Long noncoding RNA MALAT1 promotes hepatocellular carcinoma development by SRSF1 up-regulation and mTOR activation.
    Cancer Res. 2016 Dec 19. pii: canres.1508.2016.
    PubMed     Text format     Abstract available


    November 2016
  5. CHEN G, Nakamura I, Dhanasekaran R, Iguchi E, et al
    Transcriptional induction of Periostin by a Sulfatase 2-TGFbeta1-SMAD signaling axis mediates tumor angiogenesis in hepatocellular carcinoma.
    Cancer Res. 2016 Nov 21. pii: canres.2556.2015.
    PubMed     Text format     Abstract available


    October 2016
  6. MAO X, Wong SY, Tse EY, Ko FC, et al
    Mechanisms through which hypoxia-induced caveolin-1 drives tumorigenesis and metastasis in hepatocellular carcinoma.
    Cancer Res. 2016 Oct 26. pii: canres.1031.2016.
    PubMed     Text format     Abstract available


    September 2016
  7. TANG B, Qi G, Tang F, Yuan S, et al
    Aberrant JMJD3 expression upregulates Slug to promote migration, invasion and stem cell-like behaviors in hepatocellular carcinoma.
    Cancer Res. 2016 Sep 20. pii: canres.3029.2015.
    PubMed     Text format     Abstract available


  8. ALLAIN C, Angenard G, Clement B, Coulouarn C, et al
    Integrative genomic analysis identifies the core transcriptional hallmarks of human hepatocellular carcinoma.
    Cancer Res. 2016 Sep 12. pii: canres.1559.2016.
    PubMed     Text format     Abstract available


  9. ZHANG L, Ge C, Zhao F, Zhang Y, et al
    NRBP2 overexpression increases the chemosensitivity of hepatocellular carcinoma cells via Akt signaling.
    Cancer Res. 2016 Sep 7. pii: canres.0937.2016.
    PubMed     Text format     Abstract available


    August 2016
  10. WOLF B, Krieg K, Falk C, Breuhahn K, et al
    Inducing differentiation of premalignant hepatic cells as a novel therapeutic strategy in hepatocarcinoma.
    Cancer Res. 2016 Aug 3. pii: canres.3453.2015.
    PubMed     Text format     Abstract available


    June 2016
  11. LI K, Shen B, Cheng X, Ma D, et al
    Phenotypic and signaling consequences of a novel aberrantly spliced transcript FGF receptor-3 in hepatocellular carcinoma.
    Cancer Res. 2016 Jun 7. pii: canres.3385.2015.
    PubMed     Text format     Abstract available


    May 2016
  12. RIZZA S, Montagna C, Cardaci S, Maiani E, et al
    <i>S</i>-nitrosylation of the mitochondrial chaperone TRAP1 sensitizes hepatocellular carcinoma cells to inhibitors of succinate dehydrogenase.
    Cancer Res. 2016 May 23. pii: canres.2637.2015.
    PubMed     Text format     Abstract available


    April 2016
  13. HIRATA H, Sugimachi K, Komatsu H, Ueda M, et al
    Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.
    Cancer Res. 2016 Apr 6. pii: canres.2601.2015.
    PubMed     Text format     Abstract available


    March 2016
  14. LIN D, Lei L, Liu Y, Zhang Y, et al
    Membrane IL1alpha Inhibits the Development of Hepatocellular Carcinoma via Promoting T- and NK-cell Activation.
    Cancer Res. 2016.
    PubMed     Text format     Abstract available


  15. LU Y, Li N, Gao L, Xu YJ, et al
    Acetylcarnitine is a candidate diagnostic and prognostic biomarker of hepatocellular carcinoma.
    Cancer Res. 2016 Mar 14. pii: canres.3199.2015.
    PubMed     Text format     Abstract available


  16. LIU L, Zhao X, Zhao L, Li J, et al
    Arginine Methylation of SREBP1a via PRMT5 Promotes De Novo Lipogenesis and Tumor Growth.
    Cancer Res. 2016;76:1260-72.
    PubMed     Text format     Abstract available


    February 2016
  17. MARKOWITZ GJ, Yang P, Fu J, Michelotti GA, et al
    Inflammation-dependent IL-18 signaling restricts hepatocellular carcinoma growth by enhancing the accumulation and activity of tumor-infiltrating lymphocytes.
    Cancer Res. 2016 Feb 18. pii: canres.1548.2015.
    PubMed     Text format     Abstract available


  18. YE LY, Chen W, Bai XL, Xu XY, et al
    Hypoxia-Induced Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma Induces an Immunosuppressive Tumor Microenvironment to Promote Metastasis.
    Cancer Res. 2016.
    PubMed     Text format     Abstract available


    January 2016
  19. BORGHESAN M, Fusilli C, Rappa F, Panebianco C, et al
    DNA Hypomethylation and Histone Variant macroH2A1 Synergistically Attenuate Chemotherapy-Induced Senescence to Promote Hepatocellular Carcinoma Progression.
    Cancer Res. 2016.
    PubMed     Text format     Abstract available


  20. TANEI T, Leonard F, Liu X, Alexander JF, et al
    Redirecting Transport of Nanoparticle Albumin-Bound Paclitaxel to Macrophages Enhances Therapeutic Efficacy against Liver Metastases.
    Cancer Res. 2016;76:429-39.
    PubMed     Text format     Abstract available


    December 2015
  21. CHEN HN, Yuan K, Xie N, Wang K, et al
    PDLIM1 stabilizes the E-cadherin/beta-catenin complex to prevent epithelial-mesenchymal transition and metastatic potential of colorectal cancer cells.
    Cancer Res. 2015 Dec 23. pii: canres.1962.2015.
    PubMed     Text format     Abstract available


    October 2015
  22. HAM B, Wang N, D'Costa Z, Fernandez MC, et al
    TNF receptor-2 facilitates an immunosuppressive microenvironment in the liver to promote the colonization and growth of hepatic metastases.
    Cancer Res. 2015 Oct 19. pii: canres.3173.2014.
    PubMed     Text format     Abstract available


    September 2015
  23. HAYASHI H, Higashi T, Yokoyama N, Kaida T, et al
    An imbalance in TAZ and YAP expression in hepatocellular carcinoma confers cancer stem cell-like behaviors contributing to disease progression.
    Cancer Res. 2015 Sep 29. pii: canres.0291.2015.
    PubMed     Text format     Abstract available


  24. TIAN Y, Wong VW, Wong GL, Yang W, et al
    Histone deacetylase HDAC8 promotes insulin resistance and beta-catenin activation in NAFLD-associated hepatocellular carcinoma.
    Cancer Res. 2015 Sep 17. pii: canres.3786.2014.
    PubMed     Text format     Abstract available


    August 2015
  25. PHAN LM, Fuentes-Mattei E, Wu W, Velazquez-Torres G, et al
    Hepatocyte growth factor/cMET pathway activation enhances cancer hallmarks in adrenocortical carcinoma.
    Cancer Res. 2015 Aug 17. pii: canres.3707.2014.
    PubMed     Text format     Abstract available


  26. SCHMITHALS C, Koberle V, Korkusuz H, Pleli T, et al
    Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma.
    Cancer Res. 2015;75:3147-54.
    PubMed     Text format     Abstract available


    July 2015
  27. SU X, Wang H, Ge W, Yang M, et al
    An In Vivo Method to Identify microRNA Targets Not Predicted by Computation Algorithms: p21 Targeting by miR-92a in Cancer.
    Cancer Res. 2015;75:2875-85.
    PubMed     Text format     Abstract available


    June 2015
  28. ZHECHENG Z, Li T, Xie J, Shen C, et al
    Amplification of long non-coding RNA ZFAS1 promotes metastasis in hepatocellular carcinoma.
    Cancer Res. 2015 Jun 11. pii: canres.3721.2014.
    PubMed     Text format     Abstract available


    May 2015
  29. ZHANG J, Jiao J, Cermelli S, Muir K, et al
    miR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor Cells.
    Cancer Res. 2015;75:1859-67.
    PubMed     Text format     Abstract available


    April 2015
  30. BONASTRE E, Verdura S, Zondervan I, Facchinetti F, et al
    PARD3 Inactivation in Lung Squamous Cell Carcinomas Impairs STAT3 and Promotes Malignant Invasion.
    Cancer Res. 2015;75:1287-97.
    PubMed     Text format     Abstract available


    March 2015
  31. EHEDEGO H, Boekschoten MV, Hu W, Doler C, et al
    p21 ablation in liver enhances DNA damage, cholestasis, and carcinogenesis.
    Cancer Res. 2015;75:1144-55.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: